133 related articles for article (PubMed ID: 30826467)
41. Long-term treatment with an angiotensin II receptor blocker decreases adipocyte size and improves insulin signaling in obese Zucker rats.
Muñoz MC; Giani JF; Dominici FP; Turyn D; Toblli JE
J Hypertens; 2009 Dec; 27(12):2409-20. PubMed ID: 19901849
[TBL] [Abstract][Full Text] [Related]
42. Reduction of protein tyrosine phosphatase 1B increases insulin-dependent signaling in ob/ob mice.
Gum RJ; Gaede LL; Koterski SL; Heindel M; Clampit JE; Zinker BA; Trevillyan JM; Ulrich RG; Jirousek MR; Rondinone CM
Diabetes; 2003 Jan; 52(1):21-8. PubMed ID: 12502489
[TBL] [Abstract][Full Text] [Related]
43. Obesity indices and metabolic markers are related to hs-CRP and adiponectin levels in overweight and obese females.
Sanip Z; Ariffin FD; Al-Tahami BA; Sulaiman WA; Rasool AH
Obes Res Clin Pract; 2013; 7(4):e315-20. PubMed ID: 24306161
[TBL] [Abstract][Full Text] [Related]
44. Interleukin-1beta-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression.
Jager J; Grémeaux T; Cormont M; Le Marchand-Brustel Y; Tanti JF
Endocrinology; 2007 Jan; 148(1):241-51. PubMed ID: 17038556
[TBL] [Abstract][Full Text] [Related]
45. Increased pancreatic fat fraction is present in obese adolescents with metabolic syndrome.
Maggio AB; Mueller P; Wacker J; Viallon M; Belli DC; Beghetti M; Farpour-Lambert NJ; McLin VA
J Pediatr Gastroenterol Nutr; 2012 Jun; 54(6):720-6. PubMed ID: 22157928
[TBL] [Abstract][Full Text] [Related]
46. Dietary cod protein restores insulin-induced activation of phosphatidylinositol 3-kinase/Akt and GLUT4 translocation to the T-tubules in skeletal muscle of high-fat-fed obese rats.
Tremblay F; Lavigne C; Jacques H; Marette A
Diabetes; 2003 Jan; 52(1):29-37. PubMed ID: 12502490
[TBL] [Abstract][Full Text] [Related]
47. The Adipose Transcriptional Response to Insulin Is Determined by Obesity, Not Insulin Sensitivity.
Rydén M; Hrydziuszko O; Mileti E; Raman A; Bornholdt J; Boyd M; Toft E; Qvist V; Näslund E; Thorell A; Andersson DP; Dahlman I; Gao H; Sandelin A; Daub CO; Arner P
Cell Rep; 2016 Aug; 16(9):2317-26. PubMed ID: 27545890
[TBL] [Abstract][Full Text] [Related]
48. Adipose tissue and metabolic alterations: regional differences in fat cell size and number matter, but differently: a cross-sectional study.
Rydén M; Andersson DP; Bergström IB; Arner P
J Clin Endocrinol Metab; 2014 Oct; 99(10):E1870-6. PubMed ID: 24937536
[TBL] [Abstract][Full Text] [Related]
49. The expression of CCN2, IQSEC, RSPO1, DNAJC15, RIPK2, IL13RA2, IRS1, and IRS2 genes in blood of obese boys with insulin resistance.
Minchenko DO; Davydov VV; Budreiko OA; Moliavko OS; Kulieshova DK; Tiazhka OV; Minchenko OH
Fiziol Zh (1994); 2015; 61(1):10-8. PubMed ID: 26040030
[TBL] [Abstract][Full Text] [Related]
50. PKR modulates abnormal brain signaling in experimental obesity.
Taga M; Mouton-Liger F; Sadoune M; Gourmaud S; Norman J; Tible M; Thomasseau S; Paquet C; Nicoll JAR; Boche D; Hugon J
PLoS One; 2018; 13(5):e0196983. PubMed ID: 29795582
[TBL] [Abstract][Full Text] [Related]
51. Intestinal lipid handling: evidence and implication of insulin signaling abnormalities in human obese subjects.
Veilleux A; Grenier E; Marceau P; Carpentier AC; Richard D; Levy E
Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):644-53. PubMed ID: 24407032
[TBL] [Abstract][Full Text] [Related]
52. The effects of obesity-associated insulin resistance on mRNA expression of peroxisome proliferator-activated receptor-gamma target genes, in dogs.
Gayet C; Leray V; Saito M; Siliart B; Nguyen P
Br J Nutr; 2007 Sep; 98(3):497-503. PubMed ID: 17475082
[TBL] [Abstract][Full Text] [Related]
53. Insulin resistance in fat cells from obese Zucker rats--evidence for an impaired activation and translocation of protein kinase B and glucose transporter 4.
Carvalho E; Rondinone C; Smith U
Mol Cell Biochem; 2000 Mar; 206(1-2):7-16. PubMed ID: 10839189
[TBL] [Abstract][Full Text] [Related]
54. Protocatechuic acid activates key components of insulin signaling pathway mimicking insulin activity.
Scazzocchio B; Varì R; Filesi C; Del Gaudio I; D'Archivio M; Santangelo C; Iacovelli A; Galvano F; Pluchinotta FR; Giovannini C; Masella R
Mol Nutr Food Res; 2015 Aug; 59(8):1472-81. PubMed ID: 25944785
[TBL] [Abstract][Full Text] [Related]
55. [Hepatic steatosis, visceral fat and metabolic alterations in apparently healthy overweight/obese individuals].
Ryder E; Mijac V; Fernández E; Palazzi N; Morales MC; Connell L; Parra A; Romero M; Fernández N
Invest Clin; 2014 Mar; 55(1):3-14. PubMed ID: 24758097
[TBL] [Abstract][Full Text] [Related]
56. Wnt Signaling Regulates Blood Pressure by Downregulating a GSK-3β-Mediated Pathway to Enhance Insulin Signaling in the Central Nervous System.
Cheng PW; Chen YY; Cheng WH; Lu PJ; Chen HH; Chen BR; Yeh TC; Sun GC; Hsiao M; Tseng CJ
Diabetes; 2015 Oct; 64(10):3413-24. PubMed ID: 25883115
[TBL] [Abstract][Full Text] [Related]
57. mTOR inhibition with rapamycin causes impaired insulin signalling and glucose uptake in human subcutaneous and omental adipocytes.
Pereira MJ; Palming J; Rizell M; Aureliano M; Carvalho E; Svensson MK; Eriksson JW
Mol Cell Endocrinol; 2012 May; 355(1):96-105. PubMed ID: 22333157
[TBL] [Abstract][Full Text] [Related]
58. The skeletal muscle Wnt pathway may modulate insulin resistance and muscle development in a diet-induced obese rat model.
Zhou D; Strakovsky RS; Zhang X; Pan YX
Obesity (Silver Spring); 2012 Aug; 20(8):1577-84. PubMed ID: 22349736
[TBL] [Abstract][Full Text] [Related]
59. The fatty acid transporter FAT/CD36 is upregulated in subcutaneous and visceral adipose tissues in human obesity and type 2 diabetes.
Bonen A; Tandon NN; Glatz JF; Luiken JJ; Heigenhauser GJ
Int J Obes (Lond); 2006 Jun; 30(6):877-83. PubMed ID: 16418758
[TBL] [Abstract][Full Text] [Related]
60. New insights into biliverdin reductase functions: linking heme metabolism to cell signaling.
Maines MD
Physiology (Bethesda); 2005 Dec; 20():382-9. PubMed ID: 16287987
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
